nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP1A2—Clobetasol propionate—psoriasis	0.17	0.296	CbGbCtD
Rifabutin—CYP1A2—Methoxsalen—psoriasis	0.0895	0.156	CbGbCtD
Rifabutin—CYP3A4—Calcitriol—psoriasis	0.0603	0.105	CbGbCtD
Rifabutin—CYP3A4—Methoxsalen—psoriasis	0.0469	0.0816	CbGbCtD
Rifabutin—CYP3A4—Cholecalciferol—psoriasis	0.0311	0.054	CbGbCtD
Rifabutin—CYP3A4—Mycophenolate mofetil—psoriasis	0.0269	0.0468	CbGbCtD
Rifabutin—CYP3A4—Triamcinolone—psoriasis	0.0269	0.0468	CbGbCtD
Rifabutin—CYP3A4—Betamethasone—psoriasis	0.0231	0.0402	CbGbCtD
Rifabutin—CYP3A4—Prednisolone—psoriasis	0.0228	0.0397	CbGbCtD
Rifabutin—CYP3A4—Hydrocortisone—psoriasis	0.0216	0.0376	CbGbCtD
Rifabutin—CYP3A4—Prednisone—psoriasis	0.0215	0.0374	CbGbCtD
Rifabutin—CYP3A4—Cyclosporine—psoriasis	0.0204	0.0355	CbGbCtD
Rifabutin—CYP3A4—Dexamethasone—psoriasis	0.0134	0.0234	CbGbCtD
Rifabutin—HSP90AA1—Mycophenolic acid—Mycophenolate mofetil—psoriasis	0.00941	1	CbGdCrCtD
Rifabutin—HSP90AA1—endothelium—psoriasis	0.00229	0.36	CbGeAlD
Rifabutin—HSP90B1—IL6-mediated signaling events—JUN—psoriasis	0.00197	0.013	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—SOCS1—psoriasis	0.00179	0.0118	CbGpPWpGaD
Rifabutin—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.00171	0.0113	CbGpPWpGaD
Rifabutin—HSP90B1—IL6-mediated signaling events—STAT3—psoriasis	0.0017	0.0112	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KIR2DS1—psoriasis	0.00166	0.011	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL13—psoriasis	0.00155	0.0102	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—REL—psoriasis	0.00154	0.0102	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—IL10—psoriasis	0.00148	0.00979	CbGpPWpGaD
Rifabutin—HSP90AA1—EBV LMP1 signaling—CXCL8—psoriasis	0.00146	0.00967	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNFRSF1B—psoriasis	0.00146	0.00963	CbGpPWpGaD
Rifabutin—HSP90B1—Unfolded Protein Response (UPR)—CXCL8—psoriasis	0.00141	0.00932	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNFAIP3—psoriasis	0.0014	0.00926	CbGpPWpGaD
Rifabutin—HSP90AA1—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	0.00139	0.00916	CbGpPWpGaD
Rifabutin—HSP90B1—skin of body—psoriasis	0.00134	0.21	CbGeAlD
Rifabutin—HSP90AA1—EBV LMP1 signaling—NFKB1—psoriasis	0.00131	0.00865	CbGpPWpGaD
Rifabutin—HSP90AA1—NOD pathway—NFKBIA—psoriasis	0.00129	0.00853	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—DDX58—psoriasis	0.00128	0.00848	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—NFKBIA—psoriasis	0.00123	0.00814	CbGpPWpGaD
Rifabutin—HSP90B1—IL6-mediated signaling events—IL6—psoriasis	0.00119	0.00785	CbGpPWpGaD
Rifabutin—HSP90AA1—NRF2 pathway—TGFA—psoriasis	0.00105	0.00694	CbGpPWpGaD
Rifabutin—HSP90AA1—Hypoxic and oxygen homeostasis regulation of HIF-1-alpha—TP53—psoriasis	0.00105	0.00691	CbGpPWpGaD
Rifabutin—HSP90B1—tendon—psoriasis	0.00102	0.16	CbGeAlD
Rifabutin—HSP90AA1—EBV LMP1 signaling—TNF—psoriasis	0.00102	0.00673	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—TYK2—psoriasis	0.00101	0.00667	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFR1 specific signals—VEGFA—psoriasis	0.000988	0.00652	CbGpPWpGaD
Rifabutin—HSP90AA1—skin of body—psoriasis	0.000979	0.154	CbGeAlD
Rifabutin—HSP90B1—Metabolism of proteins—REN—psoriasis	0.000966	0.00638	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL4—psoriasis	0.000942	0.00622	CbGpPWpGaD
Rifabutin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000922	0.00609	CbGpPWpGaD
Rifabutin—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00091	0.00601	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000904	0.00597	CbGpPWpGaD
Rifabutin—HSP90AA1—IL2 signaling events mediated by PI3K—NFKB1—psoriasis	0.000895	0.00591	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—IFIH1—psoriasis	0.000883	0.00583	CbGpPWpGaD
Rifabutin—HSP90AA1—EPHA-mediated growth cone collapse—VEGFA—psoriasis	0.00087	0.00574	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ERAP1—psoriasis	0.000849	0.00561	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—HLA-C—psoriasis	0.000837	0.00553	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—TNFAIP3—psoriasis	0.000827	0.00546	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—JUN—psoriasis	0.000817	0.0054	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000811	0.00535	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrin-linked kinase signaling—JUN—psoriasis	0.000795	0.00525	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—NFKB1—psoriasis	0.000786	0.00519	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000782	0.00516	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—JUN—psoriasis	0.000754	0.00498	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000752	0.00497	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	0.000748	0.00494	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—DDX58—psoriasis	0.000748	0.00494	CbGpPWpGaD
Rifabutin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000747	0.00493	CbGpPWpGaD
Rifabutin—HSP90AA1—tendon—psoriasis	0.000745	0.117	CbGeAlD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000725	0.00479	CbGpPWpGaD
Rifabutin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000711	0.0047	CbGpPWpGaD
Rifabutin—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000702	0.00464	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Androgen receptor activity—JUN—psoriasis	0.000698	0.00461	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—HLA-E—psoriasis	0.000695	0.00459	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000683	0.00451	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.000677	0.00447	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—NFKBIA—psoriasis	0.000677	0.00447	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—IFNG—psoriasis	0.000661	0.00437	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000658	0.00435	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KIR2DS1—psoriasis	0.000648	0.00428	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—ACE—psoriasis	0.000603	0.00398	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000585	0.00386	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000585	0.00386	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—SOCS1—psoriasis	0.00058	0.00383	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000577	0.00381	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—JUN—psoriasis	0.000572	0.00378	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	0.000569	0.00376	CbGpPWpGaD
Rifabutin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000569	0.00376	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—ITGAL—psoriasis	0.000567	0.00374	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—TNF—psoriasis	0.000564	0.00373	CbGpPWpGaD
Rifabutin—HSP90AA1—Regulation of Telomerase—NFKB1—psoriasis	0.00055	0.00363	CbGpPWpGaD
Rifabutin—HSP90AA1—LKB1 signaling events—TP53—psoriasis	0.000544	0.0036	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—PTTG1—psoriasis	0.000534	0.00352	CbGpPWpGaD
Rifabutin—HSP90AA1—Integrins in angiogenesis—VEGFA—psoriasis	0.000531	0.00351	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—REL—psoriasis	0.00053	0.0035	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	0.000529	0.0035	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IFIH1—psoriasis	0.000515	0.0034	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—DDX58—psoriasis	0.000501	0.00331	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—psoriasis	0.000499	0.0033	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—HLA-B—psoriasis	0.000495	0.00327	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—IL6—psoriasis	0.000494	0.00326	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—JUN—psoriasis	0.000492	0.00325	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—TYK2—psoriasis	0.000491	0.00325	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HLA-C—psoriasis	0.000488	0.00322	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—CXCL8—psoriasis	0.000483	0.00319	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—TNFAIP3—psoriasis	0.000482	0.00318	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—PTTG1—psoriasis	0.000477	0.00315	CbGpPWpGaD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	0.000474	0.00313	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—TYK2—psoriasis	0.000464	0.00306	CbGpPWpGaD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—IL6—psoriasis	0.000455	0.00301	CbGpPWpGaD
Rifabutin—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000452	0.00298	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—JUN—psoriasis	0.000449	0.00296	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000442	0.00292	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—CRP—psoriasis	0.000438	0.00289	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—NFKB1—psoriasis	0.000432	0.00285	CbGpPWpGaD
Rifabutin—HSP90AA1—Corticotropin-releasing hormone—NFKB1—psoriasis	0.000432	0.00285	CbGpPWpGaD
Rifabutin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000423	0.0028	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HLA-E—psoriasis	0.000405	0.00267	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—CAT—psoriasis	0.000402	0.00266	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—NFKBIA—psoriasis	0.000399	0.00264	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000397	0.00262	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CARM1—psoriasis	0.000396	0.00262	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000391	0.00259	CbGpPWpGaD
Rifabutin—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000391	0.00258	CbGpPWpGaD
Rifabutin—HSP90AA1—EPH-Ephrin signaling—VEGFA—psoriasis	0.000385	0.00255	CbGpPWpGaD
Rifabutin—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000385	0.00254	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NDUFA5—psoriasis	0.00038	0.00251	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—LEP—psoriasis	0.000374	0.00247	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—TYK2—psoriasis	0.000351	0.00232	CbGpPWpGaD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—VEGFA—psoriasis	0.000348	0.00229	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IFIH1—psoriasis	0.000345	0.00228	CbGpPWpGaD
Rifabutin—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000342	0.00226	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—SOCS1—psoriasis	0.000338	0.00223	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNF—psoriasis	0.000336	0.00222	CbGpPWpGaD
Rifabutin—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—psoriasis	0.000335	0.00221	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERAP1—psoriasis	0.000332	0.00219	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by VEGF—VEGFA—psoriasis	0.000328	0.00217	CbGpPWpGaD
Rifabutin—Feeling abnormal—Mycophenolic acid—psoriasis	0.000328	0.00127	CcSEcCtD
Rifabutin—Chest pain—Mycophenolate mofetil—psoriasis	0.000328	0.00127	CcSEcCtD
Rifabutin—Myalgia—Mycophenolate mofetil—psoriasis	0.000328	0.00127	CcSEcCtD
Rifabutin—Arthralgia—Mycophenolate mofetil—psoriasis	0.000328	0.00127	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—TYK2—psoriasis	0.000327	0.00216	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—HLA-C—psoriasis	0.000327	0.00216	CbGpPWpGaD
Rifabutin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000327	0.00216	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000325	0.00126	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000325	0.00126	CcSEcCtD
Rifabutin—Diarrhoea—Hydroxyurea—psoriasis	0.000325	0.00126	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—psoriasis	0.000325	0.00215	CbGpPWpGaD
Rifabutin—Confusional state—Cyclosporine—psoriasis	0.000325	0.00126	CcSEcCtD
Rifabutin—Dysgeusia—Triamcinolone—psoriasis	0.000323	0.00125	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—TNFAIP3—psoriasis	0.000323	0.00213	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP2S1—psoriasis	0.000323	0.00213	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—TYK2—psoriasis	0.000323	0.00213	CbGpPWpGaD
Rifabutin—Eye disorder—Dexamethasone—psoriasis	0.000321	0.00125	CcSEcCtD
Rifabutin—Eye disorder—Betamethasone—psoriasis	0.000321	0.00125	CcSEcCtD
Rifabutin—Confusional state—Mycophenolate mofetil—psoriasis	0.000317	0.00123	CcSEcCtD
Rifabutin—Thrombocytopenia—Cyclosporine—psoriasis	0.000315	0.00122	CcSEcCtD
Rifabutin—Abdominal pain—Mycophenolic acid—psoriasis	0.000315	0.00122	CcSEcCtD
Rifabutin—Body temperature increased—Mycophenolic acid—psoriasis	0.000315	0.00122	CcSEcCtD
Rifabutin—Skin disorder—Cyclosporine—psoriasis	0.000313	0.00121	CcSEcCtD
Rifabutin—Convulsion—Prednisolone—psoriasis	0.000311	0.00121	CcSEcCtD
Rifabutin—Eosinophilia—Methotrexate—psoriasis	0.00031	0.0012	CcSEcCtD
Rifabutin—Shock—Mycophenolate mofetil—psoriasis	0.000309	0.0012	CcSEcCtD
Rifabutin—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000307	0.00119	CcSEcCtD
Rifabutin—Anorexia—Cyclosporine—psoriasis	0.000307	0.00119	CcSEcCtD
Rifabutin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000306	0.00202	CbGpPWpGaD
Rifabutin—Skin disorder—Mycophenolate mofetil—psoriasis	0.000305	0.00118	CcSEcCtD
Rifabutin—Convulsion—Hydrocortisone—psoriasis	0.000304	0.00118	CcSEcCtD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000302	0.002	CbGpPWpGaD
Rifabutin—Vomiting—Hydroxyurea—psoriasis	0.000302	0.00117	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CD8A—psoriasis	0.0003	0.00198	CbGpPWpGaD
Rifabutin—Rash—Hydroxyurea—psoriasis	0.0003	0.00116	CcSEcCtD
Rifabutin—Anorexia—Mycophenolate mofetil—psoriasis	0.000299	0.00116	CcSEcCtD
Rifabutin—Dermatitis—Hydroxyurea—psoriasis	0.000299	0.00116	CcSEcCtD
Rifabutin—Myalgia—Hydrocortisone—psoriasis	0.000298	0.00116	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—HCAR2—psoriasis	0.000298	0.00197	CbGpPWpGaD
Rifabutin—Headache—Hydroxyurea—psoriasis	0.000298	0.00115	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL6—psoriasis	0.000297	0.00196	CbGpPWpGaD
Rifabutin—Pancytopenia—Methotrexate—psoriasis	0.000297	0.00115	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000296	0.00115	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—CD4—psoriasis	0.000296	0.00195	CbGpPWpGaD
Rifabutin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000295	0.00195	CbGpPWpGaD
Rifabutin—Connective tissue disorder—Prednisone—psoriasis	0.000294	0.00114	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000293	0.00114	CcSEcCtD
Rifabutin—Neutropenia—Methotrexate—psoriasis	0.000292	0.00113	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—DDX58—psoriasis	0.000292	0.00193	CbGpPWpGaD
Rifabutin—Insomnia—Cyclosporine—psoriasis	0.000291	0.00113	CcSEcCtD
Rifabutin—Paraesthesia—Cyclosporine—psoriasis	0.000289	0.00112	CcSEcCtD
Rifabutin—HSP90B1—Immune System—HLA-B—psoriasis	0.000288	0.0019	CbGpPWpGaD
Rifabutin—Shock—Prednisolone—psoriasis	0.000288	0.00112	CcSEcCtD
Rifabutin—Dyspnoea—Cyclosporine—psoriasis	0.000287	0.00111	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000286	0.00111	CcSEcCtD
Rifabutin—Convulsion—Triamcinolone—psoriasis	0.000286	0.00111	CcSEcCtD
Rifabutin—Asthenia—Mycophenolic acid—psoriasis	0.000285	0.00111	CcSEcCtD
Rifabutin—Insomnia—Mycophenolate mofetil—psoriasis	0.000284	0.0011	CcSEcCtD
Rifabutin—Dyspepsia—Cyclosporine—psoriasis	0.000283	0.0011	CcSEcCtD
Rifabutin—Nausea—Hydroxyurea—psoriasis	0.000282	0.00109	CcSEcCtD
Rifabutin—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000282	0.00109	CcSEcCtD
Rifabutin—Pruritus—Mycophenolic acid—psoriasis	0.000281	0.00109	CcSEcCtD
Rifabutin—Shock—Hydrocortisone—psoriasis	0.000281	0.00109	CcSEcCtD
Rifabutin—Myalgia—Triamcinolone—psoriasis	0.000281	0.00109	CcSEcCtD
Rifabutin—Eye disorder—Prednisone—psoriasis	0.00028	0.00109	CcSEcCtD
Rifabutin—Dyspnoea—Mycophenolate mofetil—psoriasis	0.00028	0.00109	CcSEcCtD
Rifabutin—Decreased appetite—Cyclosporine—psoriasis	0.00028	0.00108	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000278	0.00108	CcSEcCtD
Rifabutin—Skin disorder—Hydrocortisone—psoriasis	0.000278	0.00108	CcSEcCtD
Rifabutin—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000276	0.00107	CcSEcCtD
Rifabutin—Pain—Cyclosporine—psoriasis	0.000275	0.00107	CcSEcCtD
Rifabutin—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000273	0.00106	CcSEcCtD
Rifabutin—Anorexia—Hydrocortisone—psoriasis	0.000273	0.00106	CcSEcCtD
Rifabutin—Diarrhoea—Mycophenolic acid—psoriasis	0.000272	0.00106	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—HLA-E—psoriasis	0.000271	0.00179	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—IL6—psoriasis	0.000271	0.00179	CbGpPWpGaD
Rifabutin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000271	0.00105	CcSEcCtD
Rifabutin—Immune system disorder—Prednisone—psoriasis	0.000271	0.00105	CcSEcCtD
Rifabutin—Pain—Mycophenolate mofetil—psoriasis	0.000268	0.00104	CcSEcCtD
Rifabutin—HSP90B1—Immune System—HLA-A—psoriasis	0.000267	0.00176	CbGpPWpGaD
Rifabutin—Feeling abnormal—Cyclosporine—psoriasis	0.000265	0.00103	CcSEcCtD
Rifabutin—Shock—Triamcinolone—psoriasis	0.000265	0.00103	CcSEcCtD
Rifabutin—Insomnia—Prednisolone—psoriasis	0.000265	0.00103	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—JUN—psoriasis	0.000265	0.00175	CbGpPWpGaD
Rifabutin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000264	0.00175	CbGpPWpGaD
Rifabutin—Hepatobiliary disease—Methotrexate—psoriasis	0.000264	0.00102	CcSEcCtD
Rifabutin—Gastrointestinal pain—Cyclosporine—psoriasis	0.000263	0.00102	CcSEcCtD
Rifabutin—Paraesthesia—Prednisolone—psoriasis	0.000263	0.00102	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000261	0.00101	CcSEcCtD
Rifabutin—Agranulocytosis—Methotrexate—psoriasis	0.00026	0.00101	CcSEcCtD
Rifabutin—Convulsion—Dexamethasone—psoriasis	0.000259	0.00101	CcSEcCtD
Rifabutin—Convulsion—Betamethasone—psoriasis	0.000259	0.00101	CcSEcCtD
Rifabutin—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000259	0.001	CcSEcCtD
Rifabutin—Insomnia—Hydrocortisone—psoriasis	0.000259	0.001	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—TAGAP—psoriasis	0.000259	0.00171	CbGpPWpGaD
Rifabutin—Paraesthesia—Hydrocortisone—psoriasis	0.000257	0.000996	CcSEcCtD
Rifabutin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000257	0.000995	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CRP—psoriasis	0.000255	0.00168	CbGpPWpGaD
Rifabutin—Myalgia—Dexamethasone—psoriasis	0.000255	0.000988	CcSEcCtD
Rifabutin—Myalgia—Betamethasone—psoriasis	0.000255	0.000988	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—NFKB1—psoriasis	0.000255	0.00168	CbGpPWpGaD
Rifabutin—Body temperature increased—Cyclosporine—psoriasis	0.000254	0.000986	CcSEcCtD
Rifabutin—Abdominal pain—Cyclosporine—psoriasis	0.000254	0.000986	CcSEcCtD
Rifabutin—Vomiting—Mycophenolic acid—psoriasis	0.000253	0.000981	CcSEcCtD
Rifabutin—Dyspepsia—Hydrocortisone—psoriasis	0.000252	0.000976	CcSEcCtD
Rifabutin—Rash—Mycophenolic acid—psoriasis	0.000251	0.000972	CcSEcCtD
Rifabutin—Dermatitis—Mycophenolic acid—psoriasis	0.000251	0.000972	CcSEcCtD
Rifabutin—Pain—Prednisolone—psoriasis	0.00025	0.000971	CcSEcCtD
Rifabutin—Hepatitis—Methotrexate—psoriasis	0.00025	0.000971	CcSEcCtD
Rifabutin—Headache—Mycophenolic acid—psoriasis	0.000249	0.000966	CcSEcCtD
Rifabutin—HSP90B1—Metabolism of proteins—CXCL8—psoriasis	0.000249	0.00164	CbGpPWpGaD
Rifabutin—Decreased appetite—Hydrocortisone—psoriasis	0.000249	0.000964	CcSEcCtD
Rifabutin—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000248	0.000962	CcSEcCtD
Rifabutin—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000248	0.000962	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000247	0.000957	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000245	0.000951	CcSEcCtD
Rifabutin—Pain—Hydrocortisone—psoriasis	0.000245	0.000948	CcSEcCtD
Rifabutin—HSP90B1—Immune System—HLA-DRB1—psoriasis	0.000244	0.00161	CbGpPWpGaD
Rifabutin—Insomnia—Triamcinolone—psoriasis	0.000244	0.000944	CcSEcCtD
Rifabutin—Paraesthesia—Triamcinolone—psoriasis	0.000242	0.000938	CcSEcCtD
Rifabutin—Feeling abnormal—Prednisolone—psoriasis	0.000241	0.000936	CcSEcCtD
Rifabutin—Anaemia—Prednisone—psoriasis	0.000241	0.000934	CcSEcCtD
Rifabutin—Shock—Dexamethasone—psoriasis	0.00024	0.000932	CcSEcCtD
Rifabutin—Shock—Betamethasone—psoriasis	0.00024	0.000932	CcSEcCtD
Rifabutin—HSP90AA1—VEGFA-VEGFR2 Pathway—IL6—psoriasis	0.00024	0.00159	CbGpPWpGaD
Rifabutin—Dyspnoea—Triamcinolone—psoriasis	0.00024	0.000931	CcSEcCtD
Rifabutin—Thrombocytopenia—Dexamethasone—psoriasis	0.000239	0.000928	CcSEcCtD
Rifabutin—Thrombocytopenia—Betamethasone—psoriasis	0.000239	0.000928	CcSEcCtD
Rifabutin—Hypersensitivity—Cyclosporine—psoriasis	0.000237	0.000919	CcSEcCtD
Rifabutin—Dyspepsia—Triamcinolone—psoriasis	0.000237	0.000919	CcSEcCtD
Rifabutin—Nausea—Mycophenolic acid—psoriasis	0.000236	0.000916	CcSEcCtD
Rifabutin—Feeling abnormal—Hydrocortisone—psoriasis	0.000236	0.000914	CcSEcCtD
Rifabutin—HSP90B1—Immune System—ICAM1—psoriasis	0.000234	0.00155	CbGpPWpGaD
Rifabutin—Eye disorder—Methotrexate—psoriasis	0.000234	0.000907	CcSEcCtD
Rifabutin—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000234	0.000907	CcSEcCtD
Rifabutin—Anorexia—Betamethasone—psoriasis	0.000233	0.000903	CcSEcCtD
Rifabutin—Anorexia—Dexamethasone—psoriasis	0.000233	0.000903	CcSEcCtD
Rifabutin—HSP90B1—Immune System—NFKBIA—psoriasis	0.000233	0.00154	CbGpPWpGaD
Rifabutin—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000231	0.000897	CcSEcCtD
Rifabutin—Asthenia—Cyclosporine—psoriasis	0.000231	0.000895	CcSEcCtD
Rifabutin—Pain—Triamcinolone—psoriasis	0.00023	0.000893	CcSEcCtD
Rifabutin—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	0.000229	0.00151	CbGpPWpGaD
Rifabutin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000228	0.0015	CbGpPWpGaD
Rifabutin—Pruritus—Cyclosporine—psoriasis	0.000228	0.000883	CcSEcCtD
Rifabutin—HSP90AA1—Signaling by VEGF—IL6—psoriasis	0.000227	0.0015	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—SOCS1—psoriasis	0.000227	0.0015	CbGpPWpGaD
Rifabutin—Immune system disorder—Methotrexate—psoriasis	0.000226	0.000877	CcSEcCtD
Rifabutin—Body temperature increased—Hydrocortisone—psoriasis	0.000226	0.000877	CcSEcCtD
Rifabutin—Abdominal pain—Hydrocortisone—psoriasis	0.000226	0.000877	CcSEcCtD
Rifabutin—Convulsion—Prednisone—psoriasis	0.000226	0.000876	CcSEcCtD
Rifabutin—Asthenia—Mycophenolate mofetil—psoriasis	0.000225	0.000873	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000223	0.000863	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000223	0.000863	CcSEcCtD
Rifabutin—Pruritus—Mycophenolate mofetil—psoriasis	0.000222	0.000861	CcSEcCtD
Rifabutin—Myalgia—Prednisone—psoriasis	0.000222	0.000861	CcSEcCtD
Rifabutin—Arthralgia—Prednisone—psoriasis	0.000222	0.000861	CcSEcCtD
Rifabutin—Feeling abnormal—Triamcinolone—psoriasis	0.000222	0.00086	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—ITGAL—psoriasis	0.000221	0.00146	CbGpPWpGaD
Rifabutin—Insomnia—Dexamethasone—psoriasis	0.000221	0.000857	CcSEcCtD
Rifabutin—Insomnia—Betamethasone—psoriasis	0.000221	0.000857	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.00022	0.000855	CcSEcCtD
Rifabutin—Diarrhoea—Cyclosporine—psoriasis	0.00022	0.000854	CcSEcCtD
Rifabutin—Paraesthesia—Betamethasone—psoriasis	0.000219	0.000851	CcSEcCtD
Rifabutin—Paraesthesia—Dexamethasone—psoriasis	0.000219	0.000851	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—PCNA—psoriasis	0.000217	0.00144	CbGpPWpGaD
Rifabutin—Hypersensitivity—Prednisolone—psoriasis	0.000216	0.000837	CcSEcCtD
Rifabutin—Dyspepsia—Betamethasone—psoriasis	0.000215	0.000834	CcSEcCtD
Rifabutin—Dyspepsia—Dexamethasone—psoriasis	0.000215	0.000834	CcSEcCtD
Rifabutin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000215	0.000833	CcSEcCtD
Rifabutin—Dysgeusia—Methotrexate—psoriasis	0.000213	0.000827	CcSEcCtD
Rifabutin—Body temperature increased—Triamcinolone—psoriasis	0.000213	0.000825	CcSEcCtD
Rifabutin—Decreased appetite—Betamethasone—psoriasis	0.000212	0.000824	CcSEcCtD
Rifabutin—Decreased appetite—Dexamethasone—psoriasis	0.000212	0.000824	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000211	0.000818	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000211	0.000818	CcSEcCtD
Rifabutin—Hypersensitivity—Hydrocortisone—psoriasis	0.000211	0.000817	CcSEcCtD
Rifabutin—Shock—Prednisone—psoriasis	0.000209	0.000812	CcSEcCtD
Rifabutin—Pain—Betamethasone—psoriasis	0.000209	0.00081	CcSEcCtD
Rifabutin—Pain—Dexamethasone—psoriasis	0.000209	0.00081	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—CXCL8—psoriasis	0.000208	0.00137	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—REL—psoriasis	0.000207	0.00137	CbGpPWpGaD
Rifabutin—Skin disorder—Prednisone—psoriasis	0.000207	0.000801	CcSEcCtD
Rifabutin—Asthenia—Hydrocortisone—psoriasis	0.000205	0.000796	CcSEcCtD
Rifabutin—Vomiting—Cyclosporine—psoriasis	0.000205	0.000793	CcSEcCtD
Rifabutin—Rash—Cyclosporine—psoriasis	0.000203	0.000787	CcSEcCtD
Rifabutin—Anorexia—Prednisone—psoriasis	0.000203	0.000786	CcSEcCtD
Rifabutin—Dermatitis—Cyclosporine—psoriasis	0.000203	0.000786	CcSEcCtD
Rifabutin—HSP90AA1—Axon guidance—TYK2—psoriasis	0.000203	0.00134	CbGpPWpGaD
Rifabutin—Pruritus—Hydrocortisone—psoriasis	0.000202	0.000785	CcSEcCtD
Rifabutin—Headache—Cyclosporine—psoriasis	0.000202	0.000782	CcSEcCtD
Rifabutin—Anaemia—Methotrexate—psoriasis	0.000201	0.000781	CcSEcCtD
Rifabutin—Feeling abnormal—Betamethasone—psoriasis	0.000201	0.000781	CcSEcCtD
Rifabutin—Feeling abnormal—Dexamethasone—psoriasis	0.000201	0.000781	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—IFIH1—psoriasis	0.000201	0.00133	CbGpPWpGaD
Rifabutin—Gastrointestinal pain—Dexamethasone—psoriasis	0.0002	0.000775	CcSEcCtD
Rifabutin—Gastrointestinal pain—Betamethasone—psoriasis	0.0002	0.000775	CcSEcCtD
Rifabutin—Vomiting—Mycophenolate mofetil—psoriasis	0.0002	0.000774	CcSEcCtD
Rifabutin—Hypersensitivity—Triamcinolone—psoriasis	0.000198	0.000769	CcSEcCtD
Rifabutin—Rash—Mycophenolate mofetil—psoriasis	0.000198	0.000767	CcSEcCtD
Rifabutin—Dermatitis—Mycophenolate mofetil—psoriasis	0.000198	0.000767	CcSEcCtD
Rifabutin—Headache—Mycophenolate mofetil—psoriasis	0.000197	0.000763	CcSEcCtD
Rifabutin—Diarrhoea—Hydrocortisone—psoriasis	0.000196	0.000759	CcSEcCtD
Rifabutin—Leukopenia—Methotrexate—psoriasis	0.000195	0.000756	CcSEcCtD
Rifabutin—HSP90AA1—Cell Cycle—PCNA—psoriasis	0.000194	0.00128	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Prednisone—psoriasis	0.000194	0.000752	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—HLA-B—psoriasis	0.000193	0.00128	CbGpPWpGaD
Rifabutin—Asthenia—Triamcinolone—psoriasis	0.000193	0.000749	CcSEcCtD
Rifabutin—Abdominal pain—Betamethasone—psoriasis	0.000193	0.000749	CcSEcCtD
Rifabutin—Abdominal pain—Dexamethasone—psoriasis	0.000193	0.000749	CcSEcCtD
Rifabutin—Body temperature increased—Dexamethasone—psoriasis	0.000193	0.000749	CcSEcCtD
Rifabutin—Body temperature increased—Betamethasone—psoriasis	0.000193	0.000749	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—JUN—psoriasis	0.000193	0.00128	CbGpPWpGaD
Rifabutin—Insomnia—Prednisone—psoriasis	0.000192	0.000746	CcSEcCtD
Rifabutin—Nausea—Cyclosporine—psoriasis	0.000191	0.000741	CcSEcCtD
Rifabutin—Paraesthesia—Prednisone—psoriasis	0.000191	0.000741	CcSEcCtD
Rifabutin—Pruritus—Triamcinolone—psoriasis	0.000191	0.000739	CcSEcCtD
Rifabutin—HSP90B1—Immune System—TYK2—psoriasis	0.00019	0.00126	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-C—psoriasis	0.00019	0.00126	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.00019	0.00126	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—LEP—psoriasis	0.000189	0.00125	CbGpPWpGaD
Rifabutin—Convulsion—Methotrexate—psoriasis	0.000189	0.000732	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—TNFAIP3—psoriasis	0.000188	0.00124	CbGpPWpGaD
Rifabutin—Dyspepsia—Prednisone—psoriasis	0.000187	0.000726	CcSEcCtD
Rifabutin—Nausea—Mycophenolate mofetil—psoriasis	0.000187	0.000723	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—NFKB1—psoriasis	0.000186	0.00123	CbGpPWpGaD
Rifabutin—Myalgia—Methotrexate—psoriasis	0.000186	0.000719	CcSEcCtD
Rifabutin—Chest pain—Methotrexate—psoriasis	0.000186	0.000719	CcSEcCtD
Rifabutin—Arthralgia—Methotrexate—psoriasis	0.000186	0.000719	CcSEcCtD
Rifabutin—Decreased appetite—Prednisone—psoriasis	0.000185	0.000717	CcSEcCtD
Rifabutin—Rash—Prednisolone—psoriasis	0.000185	0.000716	CcSEcCtD
Rifabutin—Dermatitis—Prednisolone—psoriasis	0.000184	0.000715	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000184	0.000714	CcSEcCtD
Rifabutin—Headache—Prednisolone—psoriasis	0.000183	0.000711	CcSEcCtD
Rifabutin—Vomiting—Hydrocortisone—psoriasis	0.000182	0.000705	CcSEcCtD
Rifabutin—Rash—Hydrocortisone—psoriasis	0.00018	0.000699	CcSEcCtD
Rifabutin—Dermatitis—Hydrocortisone—psoriasis	0.00018	0.000699	CcSEcCtD
Rifabutin—Confusional state—Methotrexate—psoriasis	0.000179	0.000695	CcSEcCtD
Rifabutin—Headache—Hydrocortisone—psoriasis	0.000179	0.000695	CcSEcCtD
Rifabutin—HSP90B1—Immune System—IFNG—psoriasis	0.000178	0.00118	CbGpPWpGaD
Rifabutin—Feeling abnormal—Prednisone—psoriasis	0.000175	0.00068	CcSEcCtD
Rifabutin—Asthenia—Betamethasone—psoriasis	0.000175	0.00068	CcSEcCtD
Rifabutin—Asthenia—Dexamethasone—psoriasis	0.000175	0.00068	CcSEcCtD
Rifabutin—Thrombocytopenia—Methotrexate—psoriasis	0.000174	0.000675	CcSEcCtD
Rifabutin—Gastrointestinal pain—Prednisone—psoriasis	0.000174	0.000675	CcSEcCtD
Rifabutin—Nausea—Prednisolone—psoriasis	0.000174	0.000674	CcSEcCtD
Rifabutin—Pruritus—Betamethasone—psoriasis	0.000173	0.00067	CcSEcCtD
Rifabutin—Pruritus—Dexamethasone—psoriasis	0.000173	0.00067	CcSEcCtD
Rifabutin—Skin disorder—Methotrexate—psoriasis	0.000173	0.00067	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CD4—psoriasis	0.000172	0.00114	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by ERBB2—IL6—psoriasis	0.000172	0.00113	CbGpPWpGaD
Rifabutin—Vomiting—Triamcinolone—psoriasis	0.000171	0.000664	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—CRP—psoriasis	0.000171	0.00113	CbGpPWpGaD
Rifabutin—Nausea—Hydrocortisone—psoriasis	0.00017	0.000659	CcSEcCtD
Rifabutin—Rash—Triamcinolone—psoriasis	0.00017	0.000658	CcSEcCtD
Rifabutin—Dermatitis—Triamcinolone—psoriasis	0.00017	0.000658	CcSEcCtD
Rifabutin—Anorexia—Methotrexate—psoriasis	0.00017	0.000657	CcSEcCtD
Rifabutin—Headache—Triamcinolone—psoriasis	0.000169	0.000654	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—VEGFA—psoriasis	0.000169	0.00111	CbGpPWpGaD
Rifabutin—Body temperature increased—Prednisone—psoriasis	0.000168	0.000652	CcSEcCtD
Rifabutin—Abdominal pain—Prednisone—psoriasis	0.000168	0.000652	CcSEcCtD
Rifabutin—Diarrhoea—Dexamethasone—psoriasis	0.000167	0.000648	CcSEcCtD
Rifabutin—Diarrhoea—Betamethasone—psoriasis	0.000167	0.000648	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—STAT3—psoriasis	0.000167	0.0011	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—PPARG—psoriasis	0.000165	0.00109	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000164	0.00109	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000162	0.000628	CcSEcCtD
Rifabutin—Insomnia—Methotrexate—psoriasis	0.000161	0.000624	CcSEcCtD
Rifabutin—Nausea—Triamcinolone—psoriasis	0.00016	0.00062	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—IL6—psoriasis	0.00016	0.00106	CbGpPWpGaD
Rifabutin—Paraesthesia—Methotrexate—psoriasis	0.00016	0.000619	CcSEcCtD
Rifabutin—Dyspnoea—Methotrexate—psoriasis	0.000159	0.000615	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000158	0.00104	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-E—psoriasis	0.000158	0.00104	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling by EGFR in Cancer—IL6—psoriasis	0.000158	0.00104	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CARM1—psoriasis	0.000158	0.00104	CbGpPWpGaD
Rifabutin—Hypersensitivity—Prednisone—psoriasis	0.000157	0.000608	CcSEcCtD
Rifabutin—Dyspepsia—Methotrexate—psoriasis	0.000157	0.000607	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—NFKBIA—psoriasis	0.000156	0.00103	CbGpPWpGaD
Rifabutin—Vomiting—Dexamethasone—psoriasis	0.000155	0.000602	CcSEcCtD
Rifabutin—Vomiting—Betamethasone—psoriasis	0.000155	0.000602	CcSEcCtD
Rifabutin—HSP90AA1—Signaling Pathways—CCL20—psoriasis	0.000155	0.00102	CbGpPWpGaD
Rifabutin—Decreased appetite—Methotrexate—psoriasis	0.000155	0.000599	CcSEcCtD
Rifabutin—HSP90B1—Immune System—JUN—psoriasis	0.000154	0.00102	CbGpPWpGaD
Rifabutin—Rash—Dexamethasone—psoriasis	0.000154	0.000597	CcSEcCtD
Rifabutin—Rash—Betamethasone—psoriasis	0.000154	0.000597	CcSEcCtD
Rifabutin—Dermatitis—Betamethasone—psoriasis	0.000154	0.000597	CcSEcCtD
Rifabutin—Dermatitis—Dexamethasone—psoriasis	0.000154	0.000597	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Methotrexate—psoriasis	0.000154	0.000595	CcSEcCtD
Rifabutin—Headache—Betamethasone—psoriasis	0.000153	0.000594	CcSEcCtD
Rifabutin—Headache—Dexamethasone—psoriasis	0.000153	0.000594	CcSEcCtD
Rifabutin—Asthenia—Prednisone—psoriasis	0.000153	0.000592	CcSEcCtD
Rifabutin—Pain—Methotrexate—psoriasis	0.000152	0.00059	CcSEcCtD
Rifabutin—Pruritus—Prednisone—psoriasis	0.000151	0.000584	CcSEcCtD
Rifabutin—HSP90B1—Immune System—NFKB1—psoriasis	0.000148	0.00098	CbGpPWpGaD
Rifabutin—Feeling abnormal—Methotrexate—psoriasis	0.000147	0.000568	CcSEcCtD
Rifabutin—Diarrhoea—Prednisone—psoriasis	0.000146	0.000565	CcSEcCtD
Rifabutin—Gastrointestinal pain—Methotrexate—psoriasis	0.000145	0.000564	CcSEcCtD
Rifabutin—Nausea—Dexamethasone—psoriasis	0.000145	0.000563	CcSEcCtD
Rifabutin—Nausea—Betamethasone—psoriasis	0.000145	0.000563	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—TYK2—psoriasis	0.000145	0.000954	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000144	0.000948	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—psoriasis	0.000143	0.000946	CbGpPWpGaD
Rifabutin—Body temperature increased—Methotrexate—psoriasis	0.000141	0.000545	CcSEcCtD
Rifabutin—Abdominal pain—Methotrexate—psoriasis	0.000141	0.000545	CcSEcCtD
Rifabutin—Vomiting—Prednisone—psoriasis	0.000135	0.000525	CcSEcCtD
Rifabutin—Rash—Prednisone—psoriasis	0.000134	0.00052	CcSEcCtD
Rifabutin—Dermatitis—Prednisone—psoriasis	0.000134	0.00052	CcSEcCtD
Rifabutin—HSP90B1—Immune System—STAT3—psoriasis	0.000133	0.000881	CbGpPWpGaD
Rifabutin—Headache—Prednisone—psoriasis	0.000133	0.000517	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—SOCS1—psoriasis	0.000132	0.000872	CbGpPWpGaD
Rifabutin—Hypersensitivity—Methotrexate—psoriasis	0.000131	0.000508	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—TYK2—psoriasis	0.000128	0.000843	CbGpPWpGaD
Rifabutin—Asthenia—Methotrexate—psoriasis	0.000128	0.000495	CcSEcCtD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—psoriasis	0.000127	0.000842	CbGpPWpGaD
Rifabutin—Nausea—Prednisone—psoriasis	0.000126	0.00049	CcSEcCtD
Rifabutin—Pruritus—Methotrexate—psoriasis	0.000126	0.000488	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000123	0.000813	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000123	0.000813	CbGpPWpGaD
Rifabutin—Diarrhoea—Methotrexate—psoriasis	0.000122	0.000472	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—CD8A—psoriasis	0.000117	0.000773	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—IL6—psoriasis	0.000117	0.000771	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CD4—psoriasis	0.000115	0.000762	CbGpPWpGaD
Rifabutin—Vomiting—Methotrexate—psoriasis	0.000113	0.000438	CcSEcCtD
Rifabutin—HSP90AA1—Developmental Biology—NFKB1—psoriasis	0.000113	0.000744	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-B—psoriasis	0.000113	0.000744	CbGpPWpGaD
Rifabutin—Rash—Methotrexate—psoriasis	0.000112	0.000435	CcSEcCtD
Rifabutin—Dermatitis—Methotrexate—psoriasis	0.000112	0.000434	CcSEcCtD
Rifabutin—Headache—Methotrexate—psoriasis	0.000111	0.000432	CcSEcCtD
Rifabutin—Nausea—Methotrexate—psoriasis	0.000106	0.00041	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—HLA-A—psoriasis	0.000104	0.000689	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—JUN—psoriasis	0.000103	0.000682	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—psoriasis	0.000102	0.000675	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—STAT3—psoriasis	0.000101	0.000668	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CRP—psoriasis	9.95e-05	0.000657	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—NFKB1—psoriasis	9.95e-05	0.000657	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—IL6—psoriasis	9.91e-05	0.000654	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CAT—psoriasis	9.69e-05	0.00064	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HLA-A—psoriasis	9.63e-05	0.000636	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-DRB1—psoriasis	9.53e-05	0.00063	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—IL6—psoriasis	9.31e-05	0.000615	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ICAM1—psoriasis	9.15e-05	0.000604	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NFKBIA—psoriasis	9.08e-05	0.000599	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APOE—psoriasis	8.99e-05	0.000594	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—psoriasis	8.76e-05	0.000578	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SOCS1—psoriasis	8.53e-05	0.000564	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS2—psoriasis	8.38e-05	0.000553	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NDUFA5—psoriasis	7.98e-05	0.000527	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—APOE—psoriasis	7.53e-05	0.000497	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.44e-05	0.000492	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TYK2—psoriasis	7.43e-05	0.000491	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—psoriasis	7.15e-05	0.000472	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—IL6—psoriasis	7.07e-05	0.000467	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNG—psoriasis	6.96e-05	0.00046	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TYK2—psoriasis	6.86e-05	0.000453	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP2S1—psoriasis	6.79e-05	0.000448	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD4—psoriasis	6.72e-05	0.000444	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PPARG—psoriasis	6.56e-05	0.000433	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOE—psoriasis	6.3e-05	0.000416	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—LEP—psoriasis	6.3e-05	0.000416	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—psoriasis	6.24e-05	0.000412	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CD4—psoriasis	6.21e-05	0.00041	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NDUFA5—psoriasis	6.16e-05	0.000407	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—JUN—psoriasis	6.02e-05	0.000397	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NFKBIA—psoriasis	5.87e-05	0.000388	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—NFKB1—psoriasis	5.79e-05	0.000383	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP2S1—psoriasis	5.24e-05	0.000346	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—STAT3—psoriasis	5.21e-05	0.000344	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TYK2—psoriasis	4.81e-05	0.000317	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—STAT3—psoriasis	4.81e-05	0.000317	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL8—psoriasis	4.19e-05	0.000276	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JUN—psoriasis	3.89e-05	0.000257	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NFKB1—psoriasis	3.75e-05	0.000247	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—psoriasis	3.64e-05	0.00024	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.56e-05	0.000235	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—psoriasis	3.4e-05	0.000224	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—STAT3—psoriasis	3.37e-05	0.000222	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—psoriasis	3.36e-05	0.000222	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CARM1—psoriasis	3.31e-05	0.000219	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.1e-05	0.000205	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—psoriasis	2.57e-05	0.00017	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CARM1—psoriasis	2.56e-05	0.000169	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—psoriasis	2.35e-05	0.000155	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CAT—psoriasis	2.04e-05	0.000135	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOE—psoriasis	1.58e-05	0.000105	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CAT—psoriasis	1.57e-05	0.000104	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARG—psoriasis	1.38e-05	9.11e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOE—psoriasis	1.22e-05	8.07e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARG—psoriasis	1.06e-05	7.03e-05	CbGpPWpGaD
